Alza, U.S. Bioscience regulatory update

The FDA approved UBS's Ethyol (amifostine) to reduce cumulative renal damage associated with repeated administration of cisplatin-based therapy in patients with non-small cell lung cancer. In December, UBS received initial clearance to market the drug for patients with advanced ovarian cancer. ...